Given the fact that melanomas, under harsh conditions, can become enriched in MITFlow cells and that these are more capable of escaping T-cell recognition, loss of MITF may be a mechanism for tumor cells to evade the immune system [9]. The gene discussed is MITF; the disease is melanoma.